scholarly journals Rare side effect of adjuvant ipilimumab after surgical resection of melanoma: Guillain-Barré syndrome

2017 ◽  
pp. bcr-2017-221318 ◽  
Author(s):  
Rohini J Patel ◽  
Michael A Liu ◽  
Akshay Amaraneni ◽  
Simran K Sindhu
2021 ◽  
Vol 10 (2) ◽  
pp. 63-64
Author(s):  
Sushmita Khanal ◽  
Sunil Babu Khanal

Guillain-Barre Syndrome has been reported as a rare side effect in the recipients of Johnson & Johnson®'s Janssen Ad26.COV2.S COVID-19 vaccine. We report a case of Guillain-Barre Syndrome in a 50 years old female following the administration of the aforementioned vaccine.


Author(s):  
ahmad matarneh ◽  
alia al-battah ◽  
khalid farooqui ◽  
mohamed ghamoodi ◽  
Mohammed alhatou

COVID-19 Virus has affected the world in many ways, resulting in several challenges. COVID 19 vaccines were introduced recently, with a variable degree of immunogenicity and safety. We report a 61-year-old man who had GBS a few days after Receiving The vaccine, his condition improved after 5 days of IVIG


2021 ◽  
Vol 9 (9) ◽  
Author(s):  
Ahmad S. Matarneh ◽  
Alia Hani Al‐battah ◽  
Khalid Farooqui ◽  
Mohamed Ghamoodi ◽  
Mohammed Alhatou

Sign in / Sign up

Export Citation Format

Share Document